<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02413619</url>
  </required_header>
  <id_info>
    <org_study_id>EPIREF</org_study_id>
    <nct_id>NCT02413619</nct_id>
  </id_info>
  <brief_title>Refractive Consequences of Epiretinal Membrane Surgery</brief_title>
  <acronym>EPIREF</acronym>
  <official_title>Refractive Consequences of Epiretinal Membrane Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Glostrup University Hospital, Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epiretinal membrane is treated with vitrectomy and peeling. Afterwards cataract is usually&#xD;
      developed, which requires a cataract surgery.&#xD;
&#xD;
      The aim of this study is to investigate the refractive consequences of surgery for Epiretinal&#xD;
      membrane and cataract.&#xD;
&#xD;
      Investigators investigate the sequence of surgery in patients having surgery for Epiretinal&#xD;
      membrane and cataract in a prospective clinically randomized intervention trial. Patients are&#xD;
      randomized to 1) start with vitrectomy, 2) start with cataract surgery, 3) combined surgery.&#xD;
      Investigators want to find the sequence of surgery that gives the most optimal refractive&#xD;
      result, the most stabile intraocular lens, and the minimal loss of corneal endothelial cells.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim: To evaluate the impact of the sequence of surgery on the Refractive Error and the&#xD;
      Corneal Endothelial Count in phakic individuals undergoing surgery for Epiretinal membrane.&#xD;
&#xD;
      Study design: Prospective interventional randomized clinical trial. Primary outcome:&#xD;
      Refractive error (i.e. Intraocular lens power prediction error), Corneal Endothelial Count,&#xD;
      and postoperative macular oedema.&#xD;
&#xD;
      Secondary outcome: Changes in axial length, anterior chamber depth and keratometry; the&#xD;
      accuracy of formulas used to calculate the power of the intraocular lens.&#xD;
&#xD;
      Study population:&#xD;
&#xD;
      Identification of participants: Individuals referred to the Macular Surgery Clinic, Surgical&#xD;
      Retina Team, Department of Ophthalmology, Glostrup University Hospital, Copenhagen, Denmark.&#xD;
      The individuals should be signed up for surgery because of Epiretinal membrane at the clinic.&#xD;
&#xD;
      Method:&#xD;
&#xD;
      Individuals are randomized to the possible sequences of surgery (i.e. start with cataract&#xD;
      surgery, start with vitrectomy, or combined surgery). Based on an estimated clinical relevant&#xD;
      refractive prediction error of 0,50 diopter and a standard deviation of 0,50 diopter, a&#xD;
      number of 20 individuals in each of the three groups are needed to obtain a power of 80 % and&#xD;
      a type 1 error of 5 %. Total number of individuals is thus 60.&#xD;
&#xD;
      Clinical examinations are performed preoperatively and 2 weeks after each surgery (cataract&#xD;
      surgery, vitrectomy or combined surgery), and 3 and 12 months postoperatively. The&#xD;
      examinations include best corrected distance visual acuity, autorefraction/keratometry&#xD;
      (Retinomax®, Nikon, Tokyo, Japan), subjective refraction, slit-lamp examination, fundoscopy&#xD;
      and tonometry. Biometry by IOLMaster (Carl Zeiss, Meditec AG, Germany), intraocular power&#xD;
      calculation with the SRK/T formula. Pentacam Scheimpflug Cornea tomography (Topcon, Tokyo,&#xD;
      Japan). Corneal Endothelial Count obtained by three images of the central region of the&#xD;
      corneal endothelium (Topcon SP-3000P, Tokyo, Japan). Heidelberg Optical Coherence Tomography,&#xD;
      (Heidelberg Engineering, Heidelberg, Germany).&#xD;
&#xD;
      Sequence of surgery depends on randomization. In all cases a standard phacoemulsification&#xD;
      (scleral tunnel or clear corneal incision) with in-the-bag intraocular lens implantation. In&#xD;
      combined surgery, the cataract surgery is performed before vitrectomy during the same&#xD;
      session. Vitreoretinal procedures include a standard three-port 23 gauge pars plana&#xD;
      vitrectomy, membrane peeling, and the use of dyes. Cataract surgery is performed by one of&#xD;
      two experienced surgeons, and vitrectomy is carried out by one experienced surgeon.&#xD;
&#xD;
      Analysis: A computer database will be created as a fill-in form to record all patient data,&#xD;
      and a masked statistical analysis of all outcome measures will be performed. Statistical&#xD;
      analysis will be performed to determine differences in baseline data among the three groups&#xD;
      (age, sex, visual acuity, keratometry, axial length, anterior chamber depth, Corneal&#xD;
      Endothelial Count). To identify independent predictors for all outcome measures at different&#xD;
      follow-up times, multivariate regression analysis is performed. All calculations will be&#xD;
      performed using SAS software.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Refractive Error</measure>
    <time_frame>One year</time_frame>
    <description>Prediction error of intraocular lens calculation (measured in diopters)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal endothelial count</measure>
    <time_frame>One year</time_frame>
    <description>measured in number of cells per square millimeter (mm2)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Macula anatomy</measure>
    <time_frame>One year</time_frame>
    <description>Macula-anatomy success of surgery, i.e. the postoperative decrease of macula thickness or postoperative macular oedema. Measured in millimeter.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anterior Chamber Depth</measure>
    <time_frame>One year</time_frame>
    <description>measured in millimeter (mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Axial length</measure>
    <time_frame>One year</time_frame>
    <description>measured in millimeter (mm)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Epiretinal Membrane</condition>
  <arm_group>
    <arm_group_label>Start cataract</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients start having cataract surgery. After one month they undergo vitrectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>start vitrectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients start having vitrectomy. After one month they undergo cataract surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>combined surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Combined cataract surgery and vitrectomy at the same time</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Vitrectomy</intervention_name>
    <description>Vitrectomy</description>
    <arm_group_label>start vitrectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cataract surgery</intervention_name>
    <description>Cataract surgery</description>
    <arm_group_label>Start cataract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Combined surgery</intervention_name>
    <description>Combined vitrectomy and cataract surgery at the same time</description>
    <arm_group_label>combined surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  A diagnosis of Epiretinal membrane,&#xD;
&#xD;
          -  visual complaints consistent with Epiretinal membrane,&#xD;
&#xD;
          -  age more than 50 years,&#xD;
&#xD;
          -  refraction less than ± 5 diopters and astigmatism less than 3 diopters,&#xD;
&#xD;
          -  indication for vitrectomy is only Epiretinal membrane.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Previous intraocular surgery or laser-refractive procedure.&#xD;
&#xD;
          -  Use of intraocular gas tamponade during the vitrectomy.&#xD;
&#xD;
          -  Intraoperative manipulation of the intraocular lens.&#xD;
&#xD;
          -  Serious complications (endophthalmitis, vitreous haemorrhage or retinal detachment).&#xD;
&#xD;
          -  History of previous head or ocular trauma.&#xD;
&#xD;
          -  Sulcus fixation of intraocular lens&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hassan Hamoudi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eye Department Glostrup Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eye Department Glostrup Hospital</name>
      <address>
        <city>Glostrup</city>
        <state>DK</state>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <study_first_submitted>March 27, 2015</study_first_submitted>
  <study_first_submitted_qc>April 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2015</study_first_posted>
  <last_update_submitted>November 9, 2016</last_update_submitted>
  <last_update_submitted_qc>November 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Glostrup University Hospital, Copenhagen</investigator_affiliation>
    <investigator_full_name>Hassan Hamoudi</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epiretinal Membrane</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

